News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Idera Pharmaceuticals, Inc. (IDRA) To Participate In A Panel Discussion At The Piper Jaffray Genomerx Symposium


6/17/2014 1:23:06 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleotide therapeutics for patients with cancer and orphan diseases, today announced that Sudhir Agrawal, D. Phil., Chief Executive Officer, will participate in a panel discussion entitled “RNA/DNA: Getting It Where You Need It” at the Piper Jaffray GenomeRx Symposium on Monday, June 23, 2014. The panel is scheduled to begin at 3:30 p.m. EDT and will take place in New York City.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES